New first-line treatment for patients with metastatic pancreatic cancer
Approved by the Food and Drug Administration on February 13, 2024. NALIRIFOX, a combination chemotherapy for first-line treatment of metastatic pancreatic adenocarcinoma. Dr. Patrick BolandI am a medical oncologist. Gastrointestinal Oncology Program We conduct research at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New Jersey’s leading cancer program and the only National Cancer […]
Vaccines targeting KRAS in pancreatic and colorectal cancers show promise
A new vaccine shows promising early results as an off-the-shelf treatment for certain patients with pancreatic or colorectal cancer, according to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK). It is said that it shows.This vaccine targets tumors with mutations (or changes) in the KRAS gene, which is the driving force […]
KRAS-targeted vaccine shows efficacy against pancreatic and colon cancer
Credit: Westend61/Getty Images Colorectal and pancreatic cancers (the second and third leading causes of cancer death, respectively) often have mutations in the KRAS protein. Now, a new vaccine targeting KRAS could be used as an off-the-shelf treatment for patients with pancreatic or colorectal cancer, according to a study co-led by researchers at Memorial Sloan Kettering […]
Motixafortide shows efficacy as primary treatment for pancreatic cancer in phase 2 trial
Pancreas image | Image credit: © Лилия Захарчук – Stock.adobe.com Motixafortide, a CXC4 inhibitor, when combined with the PD-1 inhibitor cemiplimab and the standard of care (SoC) chemotherapy treatment gemcitabine and nab-paclitaxel (MCGN) Phase 2 Data from the CheMo4METPANC trial (NCT04543071) showed some positive results against (mPDAC). This data, presented as an abstract as part […]